2m 2m 2m 2m 2m 2m 2m
AKANDA (AKAN)
NASDAQ
$1.25+$0.10 (+8.70%)
Price as of Oct 22, 2026 7:59 PM EDT- $2.7MMarket Cap
- -97.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AKANDA (AKAN)
$1.25+$0.10 (+8.70%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 56
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$1.09
$1.33
$1.15
1-Year Range
$0.45
$57.09
$1.15
Latest Close$1.15
Change
+$0.03 (+2.61%)
Volume3,089,050
Market Cap$2.7M
Shares Outstanding2.4M
P/E (TTM)-0.00008
Diluted EPS (TTM)-$14,899.95
Enterprise Value$3.3M
Information as of 10/22/2026
Company Profile
AKANDA CORP
https://www.akandacorp.com$2.7M
Market Cap
-$45.7M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
100 King St. W, Toronto, ON, Canada, M5X 1G5
416 862 7525Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Key Executives
- Christopher Robert Cooper
- Katharyn Field
- Edgar Contreras
- Gurcharn Deol
- Francisco Juarez
Current Ownership Distribution
- Other957,709 (40.10%)
- Mutual Funds725,529 (30.38%)
- Institutions697,158 (29.19%)
- Insiders7,816 (0.33%)